Respiratory Outcomes Research

  • Excess economic burden of comorbidities in COPD: a 15-year population-based study
  • Pattern and trend of COPD medication in British Columbia
  • The impact of inappropriate and excessive use of short acting beta agonists in asthma
  • Modifiable factors associated with inappropriate use of asthma relievers
  • Predictors of undiagnosed chronic obstructive pulmonary disease: a systematic review (protocol)
  • Causal association among acute exacerbations of COPD: an application of a frailty survival model
  • The Projected Epidemic Of COPD Hospitalizations Over the Next 15 Years: A Population Based Perspective
  • Ten-year trends in direct costs of asthma: a population-based study
  • Has asthma medication use caught up with the evidence? A 12-year population-based study of trends
  • Predictors of inappropriate usage of reliever medications in asthma: a 12-year population-based study
  • Excess medical costs in patients with asthma and the role of comorbidity
  • The natural history of severe asthma and influences of early risk factors: a population-based cohort study
  • History of Asthma in Patients with Chronic Obstructive Pulmonary Disease: A Comparative Study of Economic Burden.
  • The global economic burden of chronic respiratory diseases
  • Cost-effectiveness of bronchial thermoplasty, omalizumab, and standard therapy for moderate-to-severe allergic asthma
  • Influences of Socioeconomic Status on Costs of Asthma Under Universal Health Coverage
  • One-year outcomes of inhaled controller therapies added to systemic corticosteroids after asthma-related hospital discharge
  • Evaluation Platform in COPD (EPIC)
  • Economic and health effect of full adherence to controller therapy in adults with uncontrolled asthma: A simulation study
  • Economic Burden of Asthma (EBA)
  • Heterogeneity in the rate and severity of exacerbations in severe asthma: insight from a pooled analysis of two large clinical trials
  • Heterogeneity’s ruses: the neglected role of between-individual variability in longitudinal studies of COPD exacerbations
  • Post-hospital syndrome in adults with asthma: a case-crossover study
  • Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
  • Dispensation of long-acting β agonists with or without inhaled corticosteroids, and risk of asthma-related hospitalisation: a population-based study
  • Comparative outcomes of leukotriene receptor antagonists and long-acting β-agonists as add-on therapy in asthmatic patients: a population-based study
  • Costs and health outcomes associated with primary versus secondary care after an asthma-related hospitalization, a population-based study
  • A Quantitative Benefit-Risk Analysis of Isoniazid for Treatment of Latent Tuberculosis Infection Using Incremental Benefit Framework